Contributing Authors: Amanda B. Zheutlin and David A. Ross
From the Center for Genomic Medicine (ABZ), Massachusetts General Hospital, Boston, Massachusetts, and the Department of Psychiatry (DAR), Yale University, New Haven, Connecticut. Clinical Commentaries are produced in collaboration with the National Neuroscience Curriculum Initiative (NNCI). David A. Ross, in his dual roles as co-chair of the NNCI and as Education Editor of Biological Psychiatry, manages the development of these commentaries but plays no role in the decision to publish each commentary. The NNCI is supported by the National Institutes of Health Grant Nos. R25 MH08646607S1 and R44 MH115546-01.
This work was supported by a Brain and Behavior Research Foundation Young Investigator Award, the Burroughs-Wellcome Fund Career Award for Medical Scientists, the Yale Department of Psychiatry, and the Yale School of Medicine (to AP), National Institute of Mental Health Grant Nos. K23 MH115252-01A1 (to ARP) and R01MH1128875 and R01MH067073-09 (to PRC), an International Mental Health Review Order/Janssen Rising Star Translational Research Award, Clinical and Translational Science Awards Grant No. UL1 TR000142 from the National Center for Research Resources and the National Center for Advancing Translational Science, components of the National Institutes of Health, the National Institutes of Health Roadmap for Medical Research, Clinical Neurosciences Division, U.S. Department of Veterans Affairs, and the National Center for Post-Traumatic Stress Disorders, Veterans Affairs Connecticut Healthcare System (to PRC). The contents of this work are solely the responsibility of the authors and do not necessarily represent the official view of National Institutes of Health or the Connecticut Mental Health Center/Division of Mental Health and Addiction Services.
The authors report no biomedical financial interests or potential conflicts of interest.